News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Javelin Pharmaceuticals Reports Fiscal Results for the Year Ended 2008
March 12, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (NYSE - Amex: JAV) recently reported its audited financial results for the full year and quarter ending December 31, 2008.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Duchenne muscular dystrophy
Following Sarepta’s Lead, Roche Suspends Elevidys Shipments to Some Ex-US Countries
July 23, 2025
·
2 min read
·
Tristan Manalac
Podcast
Sarepta’s Wild Week, CDER’s New Leader, FDA Rejections, Manufacturing Billions
July 23, 2025
·
1 min read
·
Jef Akst
Mergers & acquisitions
Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition
July 22, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
With Potential Tariffs Weeks Away, AstraZeneca Makes $50B U.S. Manufacturing Push
July 22, 2025
·
2 min read
·
Tristan Manalac
